Publisher Correction: Targeting Toll-like receptor-driven systemic inflammation by engineering an innate structural fold into drugs.
Petruk G, Puthia M, Samsudin F, Petrlova J, Olm F, Mittendorfer M, Hyllén S, Edström D, Strömdahl AC, Diehl C, Ekström S, Walse B, Kjellström S, Bond PJ, Lindstedt S, Schmidtchen A.
Petruk G, et al. Among authors: kjellstrom s.
Nat Commun. 2023 Oct 13;14(1):6436. doi: 10.1038/s41467-023-42294-3.
Nat Commun. 2023.
PMID: 37833291
Free PMC article.
No abstract available.